Boston Scientific Adds $2B in Debt

12/10/09

Boston Scientific, the giant medical device company, said today it has raised $2 billion in a debt financing. The Natick, MA-based company (NYSE: BSX) secured interest rates ranging between 4.5 percent and 7.38 percent on notes that have to be paid back between 2015 and 2040.

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.